These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6999143)

  • 1. Effective use of captopril (angiotensin I-converting enzyme inhibitor) in severe childhood hypertension.
    Friedman A; Chesney RW; Ball D; Goodfriend T
    J Pediatr; 1980 Oct; 97(4):664-7. PubMed ID: 6999143
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of the oral angiotensin I--converting enzyme inhibitor (captopril) in childhood malignant hypertension.
    Oberfield SE; Case DB; Levine LS; Rapaport R; Rauh W; New MI
    J Pediatr; 1979 Oct; 95(4):641-4. PubMed ID: 383935
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril.
    Atkinson AB; Davies DL; Leckie B; Morton JJ; Brown JJ; Fraser R; Lever AF; Robertson JI
    Lancet; 1979 Sep; 2(8143):606-9. PubMed ID: 90271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of arterial blood pressure, plasma renin activity and plasma aldosterone concentration to long-term administration of captopril in patients with severe, treatment-resistant malignant hypertension.
    McCaa CS; Langford HG; Cushman WC; McCaa RE
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():371s-373s. PubMed ID: 396084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.
    Matthews PG; McGrath BP; Johnston CI
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():135s-138s. PubMed ID: 232017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive effect of an oral angiotensin I-converting enzyme inhibitor in two cases with malignant hypertension (author's transl)].
    Mizuno K; Gotho M; Tsutsui K; Yamazaki M; Shigetomi S; Kudo S; Matsui J; Haruyama K; Nakamura I; Toki T; Nagasawa S; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1981 Jan; 23(1):1-12. PubMed ID: 7026848
    [No Abstract]   [Full Text] [Related]  

  • 8. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA; Steilner H; Hayduk K; Liebau G
    Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone.
    Eguchi T; Saito I; Nakamura R; Yasui T; Saruta T
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):213-20. PubMed ID: 6251687
    [No Abstract]   [Full Text] [Related]  

  • 10. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of captopril in animal models of hypertension.
    Antonaccio MJ; Rubin B; Horovitz ZP
    Clin Exp Hypertens (1978); 1980; 2(3-4):613-37. PubMed ID: 7000464
    [No Abstract]   [Full Text] [Related]  

  • 12. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
    Atkinson AB; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():139s-143s. PubMed ID: 396067
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.
    Johnston CI; Millar JA; McGrath BP; Matthews PG
    Lancet; 1979 Sep; 2(8141):493-6. PubMed ID: 90216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
    Mantero F; Fallo F; Opocher G; Armanini D; Boscaro M; Scaroni C
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():289s-293s. PubMed ID: 7032817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients.
    Mizuno K; Gotoh M; Matsui J; Fukuchi S
    Jpn Heart J; 1981 Nov; 22(6):903-13. PubMed ID: 7040724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
    Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T
    Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635
    [No Abstract]   [Full Text] [Related]  

  • 17. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
    Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
    Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of an orally acting converting enzyme inhibitor: captopril.
    Brunner HR; Gavras H; Waeber B; Textor SC; Turini GA; Wauters JP
    Hypertension; 1980; 2(4):558-66. PubMed ID: 6995296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
    Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
    [No Abstract]   [Full Text] [Related]  

  • 20. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.